Clinical trials: Sphenopalatine Ganglion Nerve Block
Trigeminal Neuralgia, Headache Disorders
Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues.
Trigeminal neuralgia is one of the strongest pains known to humans. Some patients do not have enough effect with the available pharmaceutical treatments and are offered surgery.
- Trial name
- NCT02662972
- Testing
- Botulinum Toxin Type A
- Where
- Norway
- Volunteers
- 10 people
- Sponsor
- Norwegian University of Science and Technology
Migraine Disorders
Botox Injection in Treatment of Chronic Migraine
Chronic migraine is in many cases a most disabling condition. Chronic migraine is defined as headaches for at least 15 days per month, of which 8 days have typical migraine features.
- Trial name
- NCT02259075
- Testing
- Botulinum Toxin Type A
- Where
- Norway
- Volunteers
- 10 people
- Sponsor
- Norwegian University of Science and Technology
SAH (Subarachnoid Hemorrhage), Headache
Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache
The study titled \"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal…
- Trial name
- NCT06621329
- Testing
- Transnasal sphenopalatine ganglion block
- Where
- United States
- Volunteers
- 40 people
- Sponsor
- University of California, Davis
Trigeminal Neuralgia
A Nasal Applicator for the Treatment of Trigeminal Neuralgia
The pain from Trigeminal Neuralgia (TN) imposes a substantial burden on patients in daily function and reduces quality of life. The sphenopalatine ganglion, located in the posterior part of the middle nasal turbinate, is involved…
- Trial name
- NCT01761604
- Testing
- Nasal ganglion block for TN
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- Chicago Anesthesia Pain Specialists
Greater Occipital Nerve Block, Sphenopalatine Ganglion Block
Greater Occipital Nerve Blockade and Sphenopalatine Ganglion Blockade in Patients With Episodic Migraine
This study compares the effectiveness of greater occipital nerve blockade and sphenopalatine ganglion blockade in reducing headache intensity, duration, frequency, and disability in patients with episodic migraine.
- Conditions
- Greater Occipital Nerve Block, Sphenopalatine Ganglion Block, Episodic Migraine
- Trial name
- NCT06997562
- Testing
- Greater occipital nerve blockade, Sphenopalatine ganglion blockade
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- New Valley University